REQUEST A DEMO
Total
USD $0.00
Search more companies

Microbiologia Pharmaceutica S.A.S (Colombia)

Main Activities: Scientific Research and Development Services
Full name: Microbiologia Pharmaceutica S.A.S Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Microbiologia Pharmaceutica S.A.S is a company in Colombia, with a head office in Bogota D.C.. The enterprise operates in the Scientific Research and Development Services industry. It was incorporated on March 07, 2007. Microbiologia Pharmaceutica S.A.S currently employs 19 (2025) people. From the latest financial highlights, Microbiologia Pharmaceutica S.A.S reported a net sales revenue increase of 1.46% in 2024. During that time, Microbiologia Pharmaceutica S.A.S’s total assets decreased by 0.91%. In 2024, Microbiologia Pharmaceutica S.A.S’s net profit margin increased by 4.69%.

Headquarters
Cl 54 # 13-95 Con 103
Bogota D.C.; Bogota D.C; Postal Code: 0203

Contact Details: Purchase the Microbiologia Pharmaceutica S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Microbiologia Pharmaceutica S.A.S report to view the information.
Financial Auditors:
Purchase the Microbiologia Pharmaceutica S.A.S report to view the information.
Incorporation Date:
March 07, 2007
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Microbiologia Pharmaceutica S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
1.46%
Total operating revenue
1.46%
Operating profit (EBIT)
30.81%
Net Profit (Loss) for the Period
110.95%
Total Assets
-0.91%
Total Equity
13.44%
Operating Profit Margin (ROS)
3.87%
Net Profit Margin
4.69%
Return on Equity (ROE)
5.48%
Quick Ratio
1.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?